Summary
The provided AI response contains no dosing/indication/safety claims from the TOSYMRA label; however, it also makes multiple pricing/coverage/coupon claims that are not present in the supplied prescribing information excerpts and therefore cannot be verified against the label. This results in poor alignment with the FDA-approved prescribing information.
Category Scores
Accurate Statements
Unsupported Statements
The price of sumatriptan succinate can vary depending on dosage, form (tablet, nasal spray, injection), quantity, and the specific pharmacy or healthcare provider.
Not supported by the supplied TOSYMRA prescribing information excerpts.
Generic sumatriptan succinate is widely available.
Not supported by the supplied TOSYMRA prescribing information excerpts.
Generic sumatriptan succinate is generally more affordable than brand-name counterparts.
Not supported by the supplied TOSYMRA prescribing information excerpts.
For generic sumatriptan succinate tablets, prices can range from approximately $5 to $20 for a supply of 9 to 12 tablets, depending on the dosage.
Not supported by the supplied TOSYMRA prescribing information excerpts.
A prescription for nine 100 mg tablets might cost around $15 at some pharmacies.
Not supported by the supplied TOSYMRA prescribing information excerpts.
A prescription for nine 100 mg tablets might cost closer to $10 at another pharmacy.
Not supported by the supplied TOSYMRA prescribing information excerpts.
The cost for sumatriptan succinate nasal spray formulations can be higher.
Not supported by the supplied TOSYMRA prescribing information excerpts.
The cost for sumatriptan succinate injection formulations can be higher.
Not supported by the supplied TOSYMRA prescribing information excerpts.
Brand-name sumatriptan products (e.g., Imitrex) are typically more expensive than generic equivalents.
Not supported by the supplied TOSYMRA prescribing information excerpts.
Brand-name versions sometimes cost several times more than generic sumatriptan succinate.
Not supported by the supplied TOSYMRA prescribing information excerpts.
Some health insurance plans provide coverage for sumatriptan succinate, which can reduce out-of-pocket expenses.
Not supported by the supplied TOSYMRA prescribing information excerpts.
Discount programs and coupons may be available for sumatriptan succinate.
Not supported by the supplied TOSYMRA prescribing information excerpts.
Contradictions
Important Omissions
No TOSYMRA-specific prescribing information content is provided (e.g., labeled indication/limitations of use, dosing instructions, contraindications, warnings/precautions, drug interactions, adverse reactions, or relevant population information).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The response does not include dosing or safety-related instructions for TOSYMRA; therefore it does not directly contradict label safety content. However, it introduces unsupported non-label claims (pricing/coverage/coupons) that could mislead users about costs and affordability.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Misaligned
Primary Issue
All substantive claims are non-label (pricing/availability/coverage/coupons) and therefore cannot be verified against the supplied FDA-approved prescribing information excerpts.
Suggested Improvement
Limit statements to content present in the supplied TOSYMRA label excerpts (e.g., labeled acute migraine indication and limitations of use, and any dosing/contraindications/warnings only if supported by the label text provided). Remove unsupported pricing and insurance/coupon claims unless the label includes such information.